Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
08/2012
08/02/2012US20120196794 Combinations of Hepatitis C Virus Inhibitors
08/02/2012US20120196793 Biomarkers for iap inhibitor compounds
08/02/2012US20120196792 Macrocyclic hepatitis c serine protease inhibitors
08/02/2012US20120196791 Combination therapies using antibacterial aminoglycoside compounds
08/02/2012US20120196790 Cyclic depsipeptides
08/02/2012US20120196789 Peptide based peroxidase inhibitors and methods of using same
08/02/2012US20120196749 Cyclosporin Derivatives
08/02/2012US20120195979 Treatment composition for recreational water
08/02/2012US20120195978 Capcna peptide therapeutics for cancer
08/02/2012US20120195976 Methods of treating inflammation by administration of heme oxygenase-1 and products of heme degradation
08/02/2012US20120195975 Immune stimulatory infant nutrition
08/02/2012US20120195967 Silk-based drug delivery system
08/02/2012US20120195961 Use of Spinosyns and Spinosyn Compositions Against Disease Caused By Protozoans, Viral Infections and Cancer
08/02/2012US20120195959 Method for treating disease or disorder of adult central nervous system associated with tissue shrinkage or atrophy by administration of insulin
08/02/2012US20120195953 Fibrin sealant (FIBRINGLURAAS) consisting of a kit of lyophilized high concentrate fribinogen intentionally enriched and preserved with fibronolysis inhibitor A1AT
08/02/2012US20120195952 Implantable matrix having optimum ligand concentrations
08/02/2012US20120195947 Protein nanocarriers for topical delivery
08/02/2012US20120195945 Cosmetological and pharmaceutical formulae for the rejuvenation and restoration of skin, including after surgical procedures
08/02/2012US20120195939 Parenteral composition comprising microspheres with a diameter between 10 and 20 microns
08/02/2012US20120195934 Polymeric gel delivery system for pharmaceuticals
08/02/2012US20120195932 Geodate delivery vehicles
08/02/2012US20120195918 Method of treating cancer with an hla-a*3303-restricted wt1 peptide and pharmaceutical composition comprising the same
08/02/2012US20120195916 Method of treating cancer by inhibiting trim59 expression or activity
08/02/2012US20120195915 IAP BIR domain binding compounds
08/02/2012US20120195911 Method of treatment of cancer patients
08/02/2012US20120195890 Oligonucleotides inhibiting cellular migration
08/02/2012US20120195883 Monocot seed product comprising a human blood protein
08/02/2012US20120195881 Pentafluorosulfur imino heterocyclic compounds as bace-1 inhibitors, compositions and their use
08/02/2012US20120195878 Protocol for the administration of botulinum toxins
08/02/2012US20120195876 Novel role of alpha-galactosidase activity as a biomarker in kidney disease
08/02/2012US20120195875 Detection of immune modulation resulting from reduced protein phosphatase 2a activity
08/02/2012US20120195874 Dfpase enzymes from aplysia californica
08/02/2012US20120195873 Methods of attenuating the loss of functional status
08/02/2012US20120195872 Antimicrobial agents
08/02/2012US20120195871 Stable aqueous suspension
08/02/2012US20120195870 Preparations with wood extracts of locust trees
08/02/2012US20120195861 Methods and compositions for producing germ cells from peripheral blood derived germline stem cells
08/02/2012US20120195858 Responsiveness to angiogenesis inhibitors
08/02/2012US20120195857 Hepatitis C Virus Inhibitors
08/02/2012US20120195856 Method of treating patients with cardiovascular illness
08/02/2012US20120195855 Methods for up-regulating antigen expression in tumors
08/02/2012US20120195854 Granulysin in immunotherapy
08/02/2012US20120195852 Vaccines, immunotherapeutics and methods for using the same
08/02/2012US20120195851 Modified soluble fgf receptor fc fusions with improved biological activity
08/02/2012US20120195847 Polymer conjugates of biphalin peptides
08/02/2012US20120195829 Methods for identifying targeting domains and method and compositions comprising the same
08/02/2012US20120195826 Injectable biomaterial
08/02/2012DE102011003478A1 Antivirales Mittel enthaltend rekombinante Mistellektine An antiviral agent containing recombinant mistletoe lectins
08/02/2012CA2825561A1 Methods of diagnosing and treating age-related macular degeneration
08/02/2012CA2825252A1 Compositions and methods for cell transplantation
08/02/2012CA2825247A1 Human lactoferrin derived peptides and there use
08/02/2012CA2825246A1 New synthetic peptides and their use
08/02/2012CA2825211A1 Wnt compositions and methods of use thereof
08/02/2012CA2825157A1 Therapeutic or preventive agent for diabetes
08/02/2012CA2823505A1 Sense-improving agent
08/01/2012EP2481803A1 Molecules of nucleic acids coding a dextran-saccharase catalysing the synthesis of dextran having alpha-1,2 osidic branching
08/01/2012EP2481802A2 Cancer cell-specific apoptosis-inducing agents that target chromosome stabilization-associated genes
08/01/2012EP2481756A2 Compositions and methods for diagnosing and treating cancer
08/01/2012EP2481751A1 Human lactoferrin derived peptides
08/01/2012EP2481750A1 B7-DC binding antibody
08/01/2012EP2481425A1 Toll like receptor 3 antagonists, methods and uses
08/01/2012EP2481417A1 Lactase preparation
08/01/2012EP2481416A1 Eye drops
08/01/2012EP2481415A1 Activin-ActRIIa Antagonists and Uses for Promoting Bone Growth in Cancer Patients
08/01/2012EP2481401A1 Lipophilic microparticles containing a protein drug or antigen and formulation comprising same
08/01/2012EP2480579A2 Methods of treating inflammation
08/01/2012EP2480575A1 Antagonists of dsg2 for treatment of cancer
08/01/2012EP2480565A1 Peptidomimetic macrocycles
08/01/2012EP2480563A2 Bladder cancer specific ligand peptides
08/01/2012EP2480250A1 Method of treating osteoporosis with a neurotoxin
08/01/2012EP2480249A1 Use of plasmin for the treatment of filtration failure after trabeculectomy
08/01/2012EP2480248A1 Pharmaceutical composition comprising omega-3 fatty acid and hydroxy-derivative of a statin and methods of using same
08/01/2012EP2480247A2 Novel npr-b agonists
08/01/2012EP2480246A2 Composition and method for treatment of diabetes
08/01/2012EP2480245A1 A novel method for the production of a antimicrobial peptide
08/01/2012EP2480244A1 Heparin cofactor ii fragments with anti-inflammatory and anti-coagulant activity
08/01/2012EP2480243A1 Pharmaceutical compositions for treating dysregulated inflammatory diseases
08/01/2012EP2480198A2 Stabilized liquid and lyophilized adamts13 formulations
08/01/2012EP2235046B1 Mutant forms of streptolysin o
08/01/2012EP2197900B1 Mutant double cyclized receptor peptides inhibiting beta 1-adrenoceptor antibodies
08/01/2012EP2197475B1 Use of gip for the treatment of disorders associated with dysfunctional synaptic transmission
08/01/2012EP2188016B1 Use of octreotide as a therapeutic agent
08/01/2012EP2125001B1 VEGF-A or VEGF-D for use in the treatment of intra-uterine growth retardation
08/01/2012EP2112997B1 Recombinant XRGD-enriched gelatins having high stability
08/01/2012EP2091553B1 Casein-derived peptides having anxiolytic activity
08/01/2012EP2068906B1 Antiviral agent against animal viruses
08/01/2012EP1948793B1 Method for conversion of uric acid to allantoin and related enzymes
08/01/2012EP1817049B1 Soluble, stable insulin-containing formulations with a protamine salt
08/01/2012EP1728864B1 Monoclonal antibodies specific for different epitopes of human gp39 and methods for their use in diagnosis and therapy
08/01/2012EP1685159B1 Tim-3 polypeptides
08/01/2012EP1585757B1 Peptide deformylase inhibitors
08/01/2012EP1581242B1 Compositions and methods for modifying toxic effects of proteinaceous compounds
08/01/2012EP1553966B1 Fusion peptides comprising the human papillomavirus e7 and e6 polypeptides and immunogenic compositions thereof
08/01/2012EP1531865B1 Hepatocyte growth factor (HGF) and/or insulin-like growth factor-1 (IGF-1) for use in myocardial regeneration
08/01/2012EP1432407B2 Lisinopril compositions having large-particle dcpd
08/01/2012EP1425000B1 Use of polysubstituted indan-1-ol systems for producing drugs used in the prophylaxis or treatment of obesity
08/01/2012EP1333853B1 Growth factor complex
08/01/2012EP1328653B1 Highly expressible genes
08/01/2012EP1181057B1 Noninvasive genetic immunization, expression products therefrom, and uses thereof
08/01/2012EP1133310B1 Artery- and vein-specific proteins and uses therefor
1 ... 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 ... 3163